Introduction
Pulmonary embolism is diagnosed by combining clinical suspicion with targeted testing. The condition occurs when a clot, most often formed in a deep vein of the leg or pelvis, travels to the lungs and obstructs blood flow in a pulmonary artery. This blockage can reduce oxygen exchange, strain the right side of the heart, and become rapidly life-threatening. Because the symptoms can resemble many other disorders, such as pneumonia, heart failure, or anxiety-related breathing problems, accurate diagnosis is essential both to confirm the presence of an embolus and to guide urgent treatment.
Medical professionals rarely rely on symptoms alone. Instead, they estimate the likelihood of pulmonary embolism, assess risk factors, and then choose tests that can either confirm the diagnosis or safely exclude it. The diagnostic approach depends on how sick the patient appears, whether there are signs of blood clots elsewhere in the body, and whether the person can safely undergo imaging with contrast dye.
Recognizing Possible Signs of the Condition
The symptoms of pulmonary embolism are often sudden and may be nonspecific. Shortness of breath is one of the most common clues, especially when it appears abruptly or is out of proportion to the physical findings. Chest pain may also occur, often sharp and worse with breathing because the embolus can irritate the pleura or cause small areas of lung injury. A rapid heart rate is common, reflecting the body’s response to reduced oxygen delivery and impaired blood flow through the lungs.
Other findings can include coughing, occasional coughing up of blood, lightheadedness, fainting, or a feeling of impending collapse in severe cases. Some people have pain, swelling, or tenderness in one leg if the source of the clot is deep vein thrombosis. In large pulmonary emboli, low blood pressure, cyanosis, or signs of shock may appear, indicating that the heart is struggling to pump against the sudden increase in pressure in the pulmonary circulation.
Not every patient presents in a dramatic way. Smaller emboli may cause mild symptoms, and some are discovered during testing for another concern. This variability is one reason diagnosis depends on more than symptom recognition alone.
Medical History and Physical Examination
Diagnosis begins with a focused medical history. Clinicians ask about the onset, duration, and character of symptoms, especially sudden breathlessness, pleuritic chest pain, or unexplained fainting. They also look for circumstances that increase the chance of clot formation. Important risk factors include recent surgery, prolonged immobility, hospitalization, long travel, pregnancy, estrogen use, cancer, prior venous thromboembolism, inherited clotting disorders, and recent fractures or trauma.
The history also helps reveal alternative explanations. A patient with fever and productive cough may have infection, while someone with chronic exertional breathlessness may have heart or lung disease that predates the current episode. Clinicians ask whether there has been unilateral leg swelling or pain, which can suggest an active clot in the veins.
During the physical examination, healthcare professionals evaluate vital signs and general appearance. They may note tachycardia, tachypnea, low oxygen saturation, or hypotension. The lungs may sound normal even when a pulmonary embolism is present, which is an important diagnostic clue because a severe symptom burden can coexist with a relatively unrevealing chest examination. The heart exam may show signs of strain in large emboli, and the legs may be examined for swelling, warmth, tenderness, or asymmetry.
The physical examination does not confirm the diagnosis by itself, but it helps determine how urgently testing is needed and whether the patient is stable enough for standard imaging.
Diagnostic Tests Used for Pulmonary embolism
Testing is selected based on the estimated likelihood of pulmonary embolism. In low-risk patients, clinicians may start with blood tests that help rule out the condition. In higher-risk patients, imaging is often required immediately.
Laboratory tests are often the first step. The most widely used blood test is the D-dimer test, which measures a breakdown product of cross-linked fibrin. A low D-dimer level makes an acute clot less likely, especially in patients with a low or intermediate pretest probability. However, D-dimer is not specific. It can be elevated in infection, inflammation, pregnancy, cancer, recent surgery, trauma, or advanced age, so a positive result does not confirm pulmonary embolism. Other blood tests may include arterial blood gas analysis, which can show low oxygen levels or an abnormal carbon dioxide pattern, though these findings are not specific. Cardiac biomarkers such as troponin and brain natriuretic peptide may be measured in more severe cases because right ventricular strain from a large embolus can injure the heart and help predict prognosis.
Imaging tests are the main tools for confirming pulmonary embolism. The most common is computed tomography pulmonary angiography, or CTPA. This scan uses contrast dye and contrast-enhanced CT images to visualize the pulmonary arteries and detect filling defects caused by clot. It can also show alternative diagnoses such as pneumonia, aortic disease, or pleural effusion. CTPA is widely used because it is fast, accessible, and highly accurate in most patients.
When CT contrast cannot be used, a ventilation-perfusion scan, often called a V/Q scan, may be performed. This functional imaging test compares air flow into the lungs with blood flow through the pulmonary circulation. A mismatch, where ventilation is preserved but perfusion is reduced, supports pulmonary embolism. V/Q scanning is particularly useful in patients with contrast allergy, kidney impairment, or pregnancy, although interpretation can be more difficult if the lungs already have abnormal chest X-ray findings.
In unstable patients or when immediate bedside evaluation is needed, echocardiography can provide important information. While it does not directly show a clot in most cases, it can reveal right ventricular dilation, reduced right heart function, or indirect signs of pressure overload. In a critically ill patient, these findings may strongly support the diagnosis and justify urgent treatment while more definitive testing is arranged.
Ultrasound of the legs is another useful imaging study. If a deep vein thrombosis is found in a patient with symptoms suggesting pulmonary embolism, that discovery can support the diagnosis even if chest imaging is delayed or cannot be done. Because pulmonary emboli commonly originate in the deep veins, evidence of a fresh clot in the leg can be clinically decisive.
Tissue examination is not commonly needed to diagnose pulmonary embolism. There is usually no role for biopsy of lung tissue. Histologic confirmation is typically reserved for unusual situations or postmortem evaluation. In routine practice, the diagnosis is established with clinical assessment and imaging rather than tissue sampling.
Interpreting Diagnostic Results
Doctors interpret test results in the context of pretest probability, which means the estimated likelihood of disease before testing. This is important because the same result can have different meaning depending on the starting clinical suspicion. For example, a negative D-dimer in a low-risk patient can effectively rule out pulmonary embolism, but the same result would not be sufficient in a patient with a high clinical probability.
CTPA is usually considered confirmatory when it shows an intraluminal filling defect in the pulmonary arteries. The location and extent of clot burden matter because they influence treatment decisions and prognosis. A clot in a main or lobar artery may have different implications than several smaller segmental or subsegmental emboli. If the scan is technically limited or the result is equivocal, clinicians may need additional imaging or repeat testing.
V/Q scan interpretation depends on the pattern of mismatched perfusion defects. A normal perfusion study makes clinically significant pulmonary embolism unlikely. A high-probability scan, especially when matched with a compatible clinical picture, supports the diagnosis. Indeterminate scans are common in patients with abnormal lung disease and may require another imaging approach.
Biomarker results help with risk stratification more than diagnosis itself. Elevated troponin or brain natriuretic peptide suggests right heart strain and may indicate a more severe embolic event. Echocardiographic signs of right ventricular dysfunction can also point to hemodynamically significant disease, especially in a patient who is unstable.
Conditions That May Need to Be Distinguished
Several disorders can mimic pulmonary embolism because they cause chest pain, shortness of breath, or rapid breathing. Pneumonia may produce pleuritic pain, fever, and abnormal lung sounds. Acute coronary syndrome can cause chest discomfort and breathlessness, especially when the pain is not clearly pleuritic. Heart failure may lead to dyspnea and low oxygen levels, while asthma or chronic obstructive pulmonary disease can cause wheezing and respiratory distress.
Other important alternatives include pneumothorax, aortic dissection, pericarditis, musculoskeletal chest pain, and anxiety-related hyperventilation. Clinicians differentiate these conditions through a combination of history, examination, ECG, chest radiography, laboratory testing, and imaging. For example, a normal chest exam does not exclude pulmonary embolism, but a chest X-ray showing focal pneumonia or a collapsed lung can redirect the workup. An ECG may show sinus tachycardia or right heart strain in pulmonary embolism, but it may also reveal ischemia or other cardiac problems that need separate attention.
The key distinction is that pulmonary embolism reflects obstruction of the pulmonary arterial circulation, so diagnostic testing aims to identify a clot or its consequences, rather than simply documenting respiratory symptoms.
Factors That Influence Diagnosis
Several patient-specific factors affect how pulmonary embolism is evaluated. Severity is one of the most important. A patient with shock, severe hypoxia, or collapse may need bedside testing and immediate treatment before definitive imaging. In contrast, a stable patient with mild symptoms can usually undergo a more stepwise evaluation.
Age also influences the process. D-dimer levels rise with age, which reduces specificity in older adults and can lead to false positives if standard cutoffs are used. For this reason, age-adjusted D-dimer thresholds are often applied in appropriate patients. Pregnancy, recent surgery, cancer, inflammatory illness, and hospitalization can all increase baseline clot risk and also reduce the usefulness of some tests.
Kidney disease, contrast allergy, and pregnancy affect the choice of imaging. These factors may lead clinicians to prefer a V/Q scan, ultrasound of the legs, or echocardiography instead of CT angiography. Preexisting lung disease can also make V/Q interpretation harder, and obesity or motion can reduce the quality of imaging studies. In patients already taking anticoagulants, the diagnostic picture may be more complex because clotting markers and symptoms can be altered.
Clinical decision rules, such as the Wells score or similar tools, are often used to standardize the estimate of probability. These tools do not diagnose pulmonary embolism by themselves, but they help determine whether blood testing or imaging should come next.
Conclusion
Pulmonary embolism is identified through a structured process that combines clinical suspicion, risk assessment, laboratory testing, and imaging. Symptoms such as sudden breathlessness, pleuritic chest pain, tachycardia, or leg swelling raise concern, but they are not specific enough to establish the diagnosis on their own. Doctors evaluate medical history and physical findings to estimate the likelihood of clot, then use tests such as D-dimer, CTPA, V/Q scanning, leg ultrasound, echocardiography, and selected blood tests to confirm the presence of embolism and assess its severity.
The diagnostic strategy is designed to balance speed, accuracy, and patient safety. By interpreting test results in the context of clinical probability and individual patient factors, healthcare professionals can distinguish pulmonary embolism from other causes of chest pain and shortness of breath and begin the appropriate treatment without delay.